Bicara Therapeutics Inc. Common Stock (BCAX) — Defensive Interval Ratio
Bicara Therapeutics Inc. Common Stock (BCAX) has a Defensive Interval Ratio of 4011 days as of December 2025. Defensive assets of $318.12 Million (cash $-, short-term investments $318.12 Million, receivables $-) cover 4011 days of daily cash needs of $79.31K/day. Check tangible net worth ratio of Bicara Therapeutics Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Bicara Therapeutics Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Bicara Therapeutics Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 4011 days, meaning defensive assets of $318.12 Million can fund 4011 days of operations without new revenue. Also explore Bicara Therapeutics Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Bicara Therapeutics Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Bicara Therapeutics Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BCAX market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4011 days | $318.12 Million | $79.31K/day | $- | $318.12 Million | ▲ +4011 days |
| 2024 | 0 days | $0.00 | $49.29K/day | $- | $0.00 | — |